Burden, access, and disparities in kidney disease
PDF
HTML

Keywords

lesión renal aguda
enfermedad renal crónica terminal
salud global
equidad en salud
determinantes sociales de la salud.

How to Cite

1.
Crews DC, Bello AK, Saadi G. Burden, access, and disparities in kidney disease. Rev. Colomb. Nefrol. [Internet]. 2019 Mar. 1 [cited 2024 Mar. 28];6(1):74-83. Available from: https://revistanefrologia.org/index.php/rcn/article/view/341

Abstract

Kidney disease is a global public health problem that affects more than 750 million persons worldwide.1 The burden of kidney disease varies substantially across the world, as does its detection and treatment. Although the magnitude and impact of kidney disease is better defined in developed countries, emerging evidence suggests that developing countries have a similar or even greater kidney disease burden. In many settings, rates of kidney disease and the provision of its care are defined by socioeconomic, cultural, and political factors, leading to significant disparities in disease burden, even in developed countries.3 These disparities exist across the spectrum of kidney disease—from preventive efforts to curb development of acute kidney injury (AKI) or chronic kidney disease (CKD), to screening for kidney disease among persons at high risk, to access to subspecialty care and treatment of kidney failure with renal replacement therapy (RRT). World Kidney Day 2019 offers an opportunity to raise awareness of kidney disease and highlight disparities in its burden and current state of global capacity for prevention and management. In this editorial, we highlight these disparities and emphasize the role of public policies and organizational structures in addressing them. We outline opportunities to improve our understanding of disparities in kidney disease, the best ways for them to be addressed, and how to streamline efforts toward achieving kidney health equity across the globe.
https://doi.org/10.22265/acnef.6.1.341
PDF
HTML

References

1. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1603-1658.

2. Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease-a systematic review and metaanalysis. PLoS One. 2016;11:e0158765.

3. Crews DC, Liu Y, Boulware LE. Disparities in the burden, outcomes, and care of chronic kidney disease. Curr Opin Nephrol Hypertens. 2014;23:298-305.

4. Bello AK, Levin A, Tonelli M, et al. Global Kidney Health Atlas: a report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. https://www.theisn.org/images/ISN_advocacyGKHAtlas_Linked_Compressed1.pdf. Published 2017. Accessed August 22, 2018.

5. Stanifer JW, Jing B, Tolan S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta- analysis. Lancet Glob Health. 014;2:e174-e181.

6. Davids MR, Eastwood JB, Selwood NH, et al. A renal registry for Africa: first steps. Clin Kidney J. 2016;9:162-167.

7. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause- specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544.

8. Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975-1982.

9. Mehta RL, Cerda J, Burdmann EA, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385:2616-2643.

10. Samuel SM, Palacios-Derflingher L, Tonelli M, et al. Association between First Nations ethnicity and progression to kidney failure by presence and severity of albuminuria. CMAJ. 2014;186:E86-E94.

11. Nicholas SB, Kalantar-Zadeh K, Norris KC. Racial disparities in kidney disease outcomes. Semin Nephrol. 2013;33:409-415.

12. Van den Beukel TO, de Goeij MC, Dekker FW, et al. Differences in progression to ESRD between black and white patients receiving predialysis care in a universal health care system. Clin J Am Soc Nephrol. 2013;8:1540-1547.

13. Crews DC, Gutierrez OM, Fedewa SA, et al. Low income, community poverty and risk of end stage renal disease. BMC Nephrol. 2014;15:192.

14. Garrity BH, Kramer H, Vellanki K, et al. Time trends in the association of ESRD incidence with area-level poverty in the US population. Hemodial Int. 2016;20:78-83.

15. Parsa A, Kao WH, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013; 369:2183-2196.

16. Peralta CA, Bibbins-Domingo K, Vittinghoff E, et al. APOL1 genotype and race differences in incident albuminuria and renal function decline. J Am Soc Nephrol. 2016;27:887-893.

17. Correa-Rotter R. Mesoamerican nephropathy or chronic kidney disease of unknown origin. In: García- García G, Agodoa LY, Norris KC, eds. Chronic Kidney Disease in Disadvantaged Populations. Cambridge, MA: Academic Press; 2017:221-228.

18. Levin A, Stevens PE, Bilous RW, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150.

19. Chan JC, Gregg EW, Sargent J, Horton R. Reducing global diabetes burden by implementing solutions and identifying gaps: a Lancet Commission. Lancet. 2016;387:1494-1495.

20. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.

21. Plantinga LC, Miller ER 3rd, Stevens LA, et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension. 2009;54:47-56.

22. Banerjee T, Liu Y, Crews DC. Dietary patterns and CKD progression. Blood Purif. 016;41:117-122.

23. Johnson AE, Boulware LE, Anderson CA, et al. Perceived barriers and facilitators of using dietary modification for CKD prevention among African Americans of low socioeconomic status: a qualitative study. BMC Nephrol. 2014;15:194.

24. Crews DC, Kuczmarski MF, Miller ER 3rd, et al. Dietary habits, poverty, and chronic kidney disease in an urban population. J Ren Nutr. 2015;25:103-110.

25. Suarez JJ, Isakova T, Anderson CA, et al. Food access, chronic kidney disease, and hypertension in the U.S. Am J Prev Med. 2015;49:912-920.

26. Crews DC, Kuczmarski MF, Grubbs V, et al. Effect of food insecurity on chronic kidney disease in lower-income Americans. Am J Nephrol. 2014;39:27-35.

27. Banerjee T, Crews DC, Wesson DE, et al. Food insecurity, CKD, and subsequent ESRD in US adults. Am J Kidney Dis. 2017;70:38-47.

28. Piccoli GB, Alrukhaimi M, Liu ZH, et al. Women and kidney disease: reflections on World Kidney Day 2018. Kidney Int. 2018;93:278-283.

29. Food and Agriculture Organization of the United Nations. The FAO hunger map 2015. http://www.fao.org/3/a-i4674e.pdf. Published 2015. Accessed August 22, 2018.

30. Shariff ZM, Khor GL. Obesity and household food insecurity: evidence from a sample of rural households in Malaysia. Eur J Clin Nutr. 2005;59:1049-1058.

31. Popkin BM. Contemporary nutritional transition: determinants of diet and its impact on body composition. Proc Nutr Soc. 2011;70:82-91.

32. Sawhney S, Marks A, Fluck N, et al. Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study. Am J Kidney Dis. 2017;69:18-28.

33. Heung M, Steffick DE, Zivin K, et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of Veterans Health Administration data. Am J Kidney Dis. 2016;67:742-752.

34. Grams ME, Matsushita K, Sang Y, et al. Explaining the racial difference in AKI incidence. J Am Soc Nephrol. 2014;25:1834-1841.

35. Luyckx VA, Tuttle KR, Garcia-Garcia G, et al. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl. 2017;7:71-87.

36. Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int. 2013;84:457-467.

37. Cervantes L, Tuot D, Raghavan R, et al. Association of emergency-only vs standard hemodialysis with mortality and health care use among undocumented immigrants with end-stage renal disease. JAMA Intern Med. 2018;178:188-195.

38. Rizvi SA, Naqvi SA, Zafar MN, Akhtar SF. A kidney transplantation model in a low-resource country: an experience from Pakistan. Kidney Int Suppl. 2013;3:236-240.

39. Roberti J, Cummings A, Myall M, et al. Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies. BMJ Open. 2018;8:e023507.

40. Kierans C, Padilla-Altamira C, Garcia-Garcia G, et al. When health systems are barriers to health care: challenges faced by uninsured Mexican kidney patients. PLoS One. 2013;8:e54380.

41. Murray CJ, Frenk J. A framework for assessing the performance of health systems. Bull World Health Organ. 2000;78:717-731.

42. Htay H, Alrukhaimi M, Ashuntantang GE, et al. Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project. Kidney Int Suppl. 2018;8:64-73.

43. Osman MA, Alrukhaimi M, Ashuntantang GE, et al. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney Int Suppl. 2018;8:52-63.

44. World Health Organization. Global Health Observatory indicator views. http://apps.who.int/gho/data/node. imr#ndx-P. Accessed August 22, 2018.

45. Harris DC, Dupuis S, Couser WG, Feehally J. Training nephrologists from developing countries: does it have a positive impact? Kidney Int Suppl. 2012;2:275-278.

46. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80:1258-1270.

47. Chionh CY, Soni SS, Finkelstein FO, et al. Use of peritoneal dialysis in AKI: a systematic review. Clin J Am Soc Nephrol. 2013;8:1649-1660.

48. Muralidharan A, White S. The need for kidney transplantation in low- and middle- ncome countries in 2012: an epidemiological perspective. Transplantation. 015;99:476-478.
No national or foreign publication may partially or totally reproduce or translate Revista Colombiana de Nefrología articles or abstracts without prior written permission from the journal’s Editorial Board.

Dimensions


PlumX


Downloads

Download data is not yet available.